307 related articles for article (PubMed ID: 34439595)
1. Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II).
Giotta Lucifero A; Luzzi S
Brain Sci; 2021 Jul; 11(8):. PubMed ID: 34439595
[TBL] [Abstract][Full Text] [Related]
2. Gene therapies for high-grade gliomas: from the bench to the bedside.
Giotta Lucifero A; Luzzi S; Brambilla I; Guarracino C; Mosconi M; Foiadelli T; Savasta S
Acta Biomed; 2020 Jun; 91(7-S):32-50. PubMed ID: 32608374
[TBL] [Abstract][Full Text] [Related]
3. Viral therapies for glioblastoma and high-grade gliomas in adults: a systematic review.
Wang JL; Scheitler KM; Wenger NM; Elder JB
Neurosurg Focus; 2021 Feb; 50(2):E2. PubMed ID: 33524943
[TBL] [Abstract][Full Text] [Related]
4. Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I).
Giotta Lucifero A; Luzzi S
Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33803885
[TBL] [Abstract][Full Text] [Related]
5. Emerging immune-based technologies for high-grade gliomas.
Giotta Lucifero A; Luzzi S
Expert Rev Anticancer Ther; 2022 Sep; 22(9):957-980. PubMed ID: 35924820
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of the Metabolism of High-Grade Gliomas: Current Targeted Therapies and Future Perspectives.
De Maria L; Panciani PP; Zeppieri M; Ius T; Serioli S; Piazza A; Di Giovanni E; Fontanella MM; Agosti E
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255798
[TBL] [Abstract][Full Text] [Related]
7. Current Approaches for Glioma Gene Therapy and Virotherapy.
Banerjee K; Núñez FJ; Haase S; McClellan BL; Faisal SM; Carney SV; Yu J; Alghamri MS; Asad AS; Candia AJN; Varela ML; Candolfi M; Lowenstein PR; Castro MG
Front Mol Neurosci; 2021; 14():621831. PubMed ID: 33790740
[TBL] [Abstract][Full Text] [Related]
8. Potential roads for reaching the summit: an overview on target therapies for high-grade gliomas.
Giotta Lucifero A; Luzzi S; Brambilla I; Schena L; Mosconi M; Foiadelli T; Savasta S
Acta Biomed; 2020 Jun; 91(7-S):61-78. PubMed ID: 32608376
[TBL] [Abstract][Full Text] [Related]
9. Experimental therapies: gene therapies and oncolytic viruses.
Hulou MM; Cho CF; Chiocca EA; Bjerkvig R
Handb Clin Neurol; 2016; 134():183-97. PubMed ID: 26948355
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
11. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma.
Kane JR; Miska J; Young JS; Kanojia D; Kim JW; Lesniak MS
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii24-ii36. PubMed ID: 25746089
[TBL] [Abstract][Full Text] [Related]
12. Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
Koks CA; De Vleeschouwer S; Graf N; Van Gool SW
J Cancer; 2015; 6(3):203-17. PubMed ID: 25663937
[TBL] [Abstract][Full Text] [Related]
13. Innovative therapies for malignant brain tumors: the road to a tailored cure.
Giotta Lucifero A; Luzzi S; Brambilla I; Trabatti C; Mosconi M; Savasta S; Foiadelli T
Acta Biomed; 2020 Jun; 91(7-S):5-17. PubMed ID: 32608372
[TBL] [Abstract][Full Text] [Related]
14. Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma.
Bernstock JD; Blitz SE; Hoffman SE; Gerstl JVE; Chiocca EA; Friedman GK
Neurooncol Adv; 2023; 5(1):vdad081. PubMed ID: 37497017
[TBL] [Abstract][Full Text] [Related]
15. Strategies in gene therapy for glioblastoma.
Kwiatkowska A; Nandhu MS; Behera P; Chiocca EA; Viapiano MS
Cancers (Basel); 2013 Oct; 5(4):1271-305. PubMed ID: 24202446
[TBL] [Abstract][Full Text] [Related]
16. [Oncolytic viruses for therapy of malignant glioma].
Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
[TBL] [Abstract][Full Text] [Related]
17. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA
Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818
[TBL] [Abstract][Full Text] [Related]
18. Overview on current treatment standards in high-grade gliomas.
Pellerino A; Franchino F; Soffietti R; Rudà R
Q J Nucl Med Mol Imaging; 2018 Sep; 62(3):225-238. PubMed ID: 29696949
[TBL] [Abstract][Full Text] [Related]
19. [Gene Therapy and Viral Therapy for Malignant Glioma].
Kurozumi K; Koizumi S; Otani Y
No Shinkei Geka; 2021 May; 49(3):608-616. PubMed ID: 34092566
[TBL] [Abstract][Full Text] [Related]
20. Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma.
Panek WK; Kane JR; Young JS; Rashidi A; Kim JW; Kanojia D; Lesniak MS
Oncotarget; 2017 Oct; 8(51):89391-89405. PubMed ID: 29179527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
